Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-037573

Director sold 15,000 shares at $10.72 ($160,857)

From the SEC's structured data for this filing

Trades in this filing

Gould Robert J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form −15,000 $10.72 $160,857 454,864 D
Open-market sales · 15,000 sh · avg $10.72 · $160,857
Loading xslF345X05/ownership.xml…